| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | 1 | — | — | — | — | — | — |
| Sell | — | 8 | 1 | — | 8 | 1 | — | 8 | — | — | 8 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.00 |
—
—
—
—
|
| 2025 | 1.82 |
—
—
—
—
|
| 2024 | 1.62 |
—
—
—
—
|
| 2023 | 1.50 |
—
—
—
—
|
| 2022 | 1.44 |
—
—
—
—
|
| 2021 | 0.95 |
—
—
—
|
| 2020 | 1.52 |
—
—
—
—
—
|
| 2019 | 1.12 |
—
—
—
—
|
| 2018 | 1.00 |
—
—
—
—
|
| 2017 | 0.92 |
—
—
—
—
|
| 2016 | 0.88 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 389.00 | 551.00 | 528.70 | 523.80 |
| Receivables | 344.50 | 370.50 | 406.60 | 395.60 |
| Inventory | — | — | — | — |
| Other | 5.40 | 11.30 | 24.80 | 24.50 |
| 815.70 | 1,014.10 | 1,038.00 | 1,034.90 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 78.40 | 87.30 | 97.90 | 91.90 |
| ST’ Debt | 32.10 | — | — | 18.20 |
| Other | 1.80 | 1.40 | 9.30 | 4.00 |
| 880.80 | 967.30 | 1,053.30 | 980.30 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 644.80 | 663.20 | — | — |
—
|
| ’25 | 581.90 | 605.10 | 617.40 | 641.10 |
2,445.50
|
| ’24 | 542.80 | 571.90 | 569.40 | 591.00 |
2,275.10
|
| ’23 | 479.70 | 504.70 | 515.50 | 538.70 |
2,038.60
|
| ’22 | 457.00 | 470.40 | 468.20 | 475.00 |
1,870.60
|
| ’21 | 392.80 | 415.40 | 428.90 | 462.20 |
1,699.30
|
| ’20 | 324.00 | 327.90 | 357.20 | 380.40 |
1,389.50
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 91.50 | 155.70 | — | — |
—
|
| ’25 | 91.00 | 99.00 | 195.70 | 204.00 |
589.70
|
| ’24 | 93.60 | 152.70 | 191.90 | 153.40 |
591.60
|
| ’23 | 23.40 | 24.50 | 130.70 | 137.80 |
316.40
|
| ’22 | 23.50 | 68.70 | 102.10 | 103.50 |
297.80
|
| ’21 | 64.20 | 127.20 | 122.60 | 135.90 |
449.90
|
| ’20 | 48.70 | 127.60 | 93.40 | 114.60 |
384.30
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 53.60 | 122.50 | — | — |
—
|
| ’25 | 58.80 | 62.40 | 160.10 | 161.30 |
442.60
|
| ’24 | 59.50 | 120.80 | 155.80 | 112.80 |
448.90
|
| ’23 | (6.10) | (5.80) | 101.40 | 107.80 |
197.30
|
| ’22 | (4.50) | 37.00 | 68.40 | 67.40 |
168.30
|
| ’21 | 41.50 | 108.50 | 92.40 | 105.70 |
348.10
|
| ’20 | 33.60 | 110.60 | 70.80 | 92.60 |
307.60
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.73 | 2.83 | — | — |
—
|
| ’25 | 1.82 | 2.09 | 2.17 | 2.83 |
8.87
|
| ’24 | 1.49 | 1.60 | 2.77 | 2.71 |
8.58
|
| ’23 | (0.18) | 0.84 | 0.91 | 1.71 |
3.29
|
| ’22 | 1.06 | 0.70 | (0.21) | 0.08 |
1.64
|
| ’21 | 1.27 | 0.76 | 1.13 | 1.30 |
4.45
|
| ’20 | 0.55 | 1.12 | 1.76 | 1.74 |
5.18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 207.11 | 163.28 | 269.51 | 202.89 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 343.54 | 289.17 | 365.00 | 338.50 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12,224 | 11,334 | 11,085 | 10,973 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.15 | 0.18 | 0.21 | 0.22 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,870.60 | 2,038.60 | 2,275.10 | 2,445.50 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 58.34% | 58.62% | 60.63% | 61.03% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 130.60 | 181.50 | 491.30 | 499.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.98% | 8.90% | 21.59% | 20.40% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 70.50 | 141.10 | 369.90 | 374.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 166.60 | 184.90 | 190.40 | 189.90 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.91 | 47.85 | 53.16 | 58.37 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | 1.65 | 3.31 | 8.64 | 8.93 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.99 | 7.43 | 13.82 | 14.07 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.04) | (2.80) | (3.33) | (3.51) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.95 | 4.63 | 10.49 | 10.56 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.34 | 31.17 | 37.82 | 29.16 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.60 | 42.60 | 42.80 | 41.90 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 132.20 | 83.87 | 39.07 | 24.25 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.97 | 5.80 | 6.34 | 3.72 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.70 | 8.91 | 8.90 | 7.45 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.34 | 6.09 | 6.41 | 3.96 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.34 | 62.89 | 32.51 | 21.87 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 297.80 | 316.40 | 591.60 | 589.70 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (129.50) | (119.10) | (142.70) | (147.10) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 168.30 | 197.30 | 448.90 | 442.60 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (71.70) | (65.10) | 46.80 | (15.30) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,109.60 | 972.40 | 698.60 | 1,072.60 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 695.00 | 583.40 | 147.60 | 543.90 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,207.10 | 1,327.80 | 1,618.60 | 1,221.90 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.22% | 4.10% | 10.64% | 10.48% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.51% | 7.54% | 17.16% | 18.64% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.38% | 11.13% | 25.11% | 26.35% | ‡‡‡‡‡ | — | — |
ROE
|
Morningstar, Inc. (MORN) has engineered a robust transformation over the past decade, scaling revenue from $799 million in 2016 to $2.275 billion in 2024—a 185% surge at 14% CAGR—through strategic acquisitions like PitchBook and expansions into workplace solutions and ESG analytics. This subscription-driven model (over 80% recurring revenue) delivered steady gross margins of 58-60% and rebounding efficiency, with revenue per employee jumping 34% to $205,000 in 2024. Yet, the stock has decoupled sharply, trading 56% below 2024 highs amid insider selling exceeding $90 million (zero buys) and macro headwinds, masking a dramatic profitability turnaround: EBT margins rocketed from 7% in 2022 to 22% last year, net income soared 162%, and free cash flow per share surged 126% to $10.49.
Balance sheet strength bolsters the case, with net debt slashed 75% to $148 million, equity up 22%, and ROE hitting 25%. Current valuations appear compressed at 19x forward PE, 3x EV/Sales, and reasonable multiples versus a high-moat data business. Analysts project 7-8% revenue CAGR through 2027, accelerating EPS to mid-teens growth (reaching $11.82), implying 20-75% upside from recent lows—trading like a turnaround despite solid fundamentals.
Forward catalysts like AI-enhanced analytics and potential spin-offs contrast with risks such as persistent insider caution, capex efficiency, and recessionary pressures. This blend of operational resilience and market skepticism positions MORN as a compelling watch for patient investors seeking undervalued compounding.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.